Pfizer tops forecasts on higher sales, lower taxes
Drugmaker raised its financial forecasts, citing strong operational performance in the quarter and an improved business outlook
Pfizer
Shareholders give Pfizer an earful over scrapped Allergan deal
Deal was structured as an inversion, in which a U.S. company moves its headquarters on paper to another country with lower tax rates
Which stock to buy now, Pfizer or Allergan?
Actually, a good argument can be made for buying both because each company is strong with good future prospects
Pfizer's next takeover target will be American
It failed on the tax-favored Allergan deal, but it still needs to expand -- only now it will be looking closer to home
Big mergers are getting tougher to pull off
As both Pfizer-Allergan and Halliburton-Baker Hughes got government thumbs-down this week, it shows things are changing
$160 billion Pfizer-Allergan deal is dead
End of Pfizer's tax-cutting "inversion" buy of fellow drug maker would come after Obama and Treasury Dept. took aim at such agreements
Analysts: New inversion rules will kill $160B Pfizer-Allergan deal
Drugmakers scramble to figure whether to proceed with their plan to merge and move address to lower-tax Ireland
Allergan shares tumble on new tax inversion rules
Treasury's harder push against mergers that relocate U.S. firms overseas to save taxes threatens the deal with Pfizer
Drug ads: $5.2 billion annually -- and rising
Nine out 10 big pharma companies spend more on marketing than on R&D, but what are consumers getting in return?
Pfizer earnings fall but top forecasts
Company benefited from growing sales of its newest products, as well as the additional of injectable medicines made by Hospira
Drugmakers ring in 2016 with hefty price hikes
Big pharma is busily raising prices on dozens of medications, branded and generic, with increases of 20 percent or more
Hillary Clinton says no to corporate tax inversions
The Democratic presidential candidate vows to take executive action to halt the scheme that lets U.S. firms cut their taxes
Will Pfizer bring its tax bonanza back to the U.S.?
To hear CEO tell it, takeover of Allergan will free up cash to invest and hire domestically -- don't bank on it
5 things to know about the biggest ever drug merger
Pfizer and Allergan have inked a record $160 billion deal -- what does it mean for investors and consumers?
Pfizer, Allergan combining in $160 billion deal
Deal, which creates the world's biggest drugmaker, uses a highly controversial method to drastically cut Pfizer's tax tab
U.S. toughens rules in corporate tax dodges
Transactions such as mergers that result in U.S. companies relocating HQ overseas to avoid taxes just got a little harder
Why Pfizer is so bent on lowering its tax rate
CEO Ian Read is a poster boy for critics who have long complained about the U.S. corporate tax system being unfair
Pfizer's CEO may have the deal he's looking for
By buying Ireland-based Allergan, Ian Read would cut Pfizer's U.S. tax bill while adding valuable products such as Botox
Allergan confirms Pfizer approach, companies in talks
Botox maker confirms that it has been approached by about a possible merger
What to do when CVS/caremark drops Viagra coverage
A big prescription drug insurance plan is dropping Viagra next year, but there are alternatives to the little blue pill
DOJ takes steps to charge James Comey again
These factors could decide Netanyahu's fate in Israel's election
First on CBS
Trump's oil and gas stocks gained millions during Iran war
Court dismisses DOJ's request to force California to set aside ballots
Maurene Comey, James Comey's daughter, was unlawfully fired, judge rules
Live
Iran shrugs off Trump's attack threats, says diplomacy ongoing
Duchess Meghan confronted dad over child abuse claims last year
Walter Koenig, actor who played Chekov on "Star Trek," dies at 90
